These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1726443)

  • 1. Platelet-activating factor (PAF) in allergic diseases: inhibitory effects of anti-allergic drugs, ketotifen and three kampo medicines on PAF production.
    Nakamura T; Kuriyama M; Ishihara K; Matsumura Y; Miyamoto T
    Lipids; 1991 Dec; 26(12):1297-300. PubMed ID: 1726443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet-activating factor in Japanese cedar pollinosis].
    Nakamura T; Ishihara K; Kuriyama M; Miyamoto T; Matsumura Y
    Arerugi; 1990 Jun; 39(6):553-6. PubMed ID: 2222198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor in Japanese cedar pollinosis.
    Nakamura T; Ishihara K; Kuriyama M; Ito K; Matsumura Y
    J Lipid Mediat; 1992; 5(2):193-5. PubMed ID: 1525363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-allergic effects of a cromolyn sodium-chlorpheniramine combination compared to ketotifen in the conjunctival allergen challenge model.
    Leonardi A; Busca F; Tavolato M; Secchi AG
    Eur J Ophthalmol; 2003 Mar; 13(2):128-33. PubMed ID: 12696630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
    Ueno M; Inagaki N; Nagai H; Koda A
    Pharmacology; 1998 Oct; 57(4):206-14. PubMed ID: 9730778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents].
    Yamada N; Takahashi K; Endoh K; Arai Y
    Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):229-37. PubMed ID: 2431983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of saiboku-to (TJ-96) on the production of platelet-activating factor in human neutrophils.
    Nakamura T; Kuriyama M; Kosuge E; Ishihara K; Ito K
    Ann N Y Acad Sci; 1993 Jun; 685():572-9. PubMed ID: 8363265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease of ciliary beat frequency by platelet activating factor: protective effect of ketotifen.
    Kahhak L; Roche A; Dubray C; Arnoux C; Benveniste J
    Inflamm Res; 1996 May; 45(5):234-8. PubMed ID: 8737746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human and rabbit platelet activation by Ketotifen.
    Devillier P; Arnoux B; Lalau Keraly C; Landes A; Marsac J; Benveniste J
    Fundam Clin Pharmacol; 1990; 4(1):1-9. PubMed ID: 2111270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
    Mita H; Shida T
    Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen.
    Dake Y; Enomoto T; Cheng L; Enomoto K; Shibano A; Ikeda H; Yoda S; Yajin S; Sakota T; Yamanishi E
    Allergol Int; 2006 Dec; 55(4):373-8. PubMed ID: 17130679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitor of chemical mediator release].
    Fujimura M
    Nihon Rinsho; 1996 Nov; 54(11):3029-33. PubMed ID: 8950949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation.
    Welch EJ; Naikawadi RP; Li Z; Lin P; Ishii S; Shimizu T; Tiruppathi C; Du X; Subbaiah PV; Ye RD
    Mol Pharmacol; 2009 Jan; 75(1):227-34. PubMed ID: 18931035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-allergic drugs on human neutrophil superoxide-generating NADPH oxidase.
    Umeki S
    Biochem Pharmacol; 1992 Mar; 43(5):1109-17. PubMed ID: 1372806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picumast dihydrochloride (Auteral), a new anti-allergic inhibitor of mediator release and action.
    Wilhelms OH; Roesch A; Schaumann W
    Agents Actions Suppl; 1991; 34():335-49. PubMed ID: 1686528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of ketotifen on rabbit platelet aggregation and platelet activating factor formation from rat neutrophils].
    Wang XD; Bian RL
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):524-7. PubMed ID: 2130617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of allergies.
    De Vos C
    Allerg Immunol (Paris); 1992 Dec; 24(10):382-4. PubMed ID: 1363195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathophysiological evaluation of tranilast in patients with pollinosis: the effects of pre-seasonal treatment.
    Ukai K; Masuda S; Shinoki J; Sakakura Y
    Auris Nasus Larynx; 1993; 20(4):275-84. PubMed ID: 7513512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitory effect of ketotifen on in vitro histamine release in allergic patients.
    Oehling A; Ona J; Wierna G; Sanz ML; Castillo J
    Allergol Immunopathol (Madr); 1985; 13(6):475-85. PubMed ID: 2421563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of azelastine and ketotifen on the bronchial and skin responses to platelet-activating factor in humans.
    Lai CK; Ollier S; Lau CK; Holgate ST
    Clin Exp Allergy; 1991 Jul; 21(4):489-96. PubMed ID: 1680533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.